Douglas D. Cusick is a seasoned healthcare executive with deep expertise in healthcare IT and a proven track record of transformative leadership. As President of S&P Universal Consulting, he leverages his extensive experience to drive strategic growth and deliver exceptional value to healthcare organizations navigating complex challenges in IT, clinical optimization, change management and governance.
A pharmacist by profession, Doug brings over two decades of healthcare leadership experience across provider, payer, and life sciences sectors. His career encompasses executive roles at industry leaders including Nordic Global Consulting, GeneDx (formerly Sema4), TransformativeMed, IDX Systems, Healthlink, Clinovations, and Aetna. As CEO of TransformativeMed, he achieved consistent annual revenue growth between 25-42% over four years, successfully led a Series A funding round, and positioned the company for acquisition.
Known for his execution-minded approach, Doug has a demonstrated ability to transform organizations, build high-performance teams, and drive ambitious business goals. His international work experience spans over 70 countries, giving him a global perspective on healthcare IT challenges and solutions. This international expertise perfectly positions him to lead S&P Universal’s global consulting practice while maintaining strong connections with its affiliate, S&P Federal, serving the U.S. public sector.
Doug combines strategic vision with operational excellence, bringing measurable value and organizational focus to his S&P Universal clients.
